国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Candida glabrata Histone H2B.2 (HTB2) CSB-YP738908CZI
CSB-EP738908CZI
CSB-BP738908CZI
CSB-MP738908CZI
CSB-EP738908CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Riboflavin kinase (FMN1) CSB-YP738909CZI
CSB-EP738909CZI
CSB-BP738909CZI
CSB-MP738909CZI
CSB-EP738909CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata RNA polymerase II transcription factor B subunit 5 (TFB5) CSB-YP738910CZI
CSB-EP738910CZI
CSB-BP738910CZI
CSB-MP738910CZI
CSB-EP738910CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Protein FYV6 (FYV6) CSB-YP738911CZI
CSB-EP738911CZI
CSB-BP738911CZI
CSB-MP738911CZI
CSB-EP738911CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Mitochondrial distribution and morphology protein 32 (MDM32), partial CSB-YP738912CZI1
CSB-EP738912CZI1
CSB-BP738912CZI1
CSB-MP738912CZI1
CSB-EP738912CZI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata ASTRA-associated protein 1 (ASA1) CSB-YP738913CZI
CSB-EP738913CZI
CSB-BP738913CZI
CSB-MP738913CZI
CSB-EP738913CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Structure-specific endonuclease subunit SLX1 (SLX1) CSB-YP738914CZI
CSB-EP738914CZI
CSB-BP738914CZI
CSB-MP738914CZI
CSB-EP738914CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Probable kinetochore protein SPC24 (SPC24) CSB-YP738915CZI
CSB-EP738915CZI
CSB-BP738915CZI
CSB-MP738915CZI
CSB-EP738915CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Serine/threonine-protein kinase STE20 (STE20), partial CSB-YP738916CZI
CSB-EP738916CZI
CSB-BP738916CZI
CSB-MP738916CZI
CSB-EP738916CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Phosphatidylglycerol/phosphatidylinositol transfer protein (NPC2) CSB-YP738917CZI
CSB-EP738917CZI
CSB-BP738917CZI
CSB-MP738917CZI
CSB-EP738917CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata H/ACA ribonucleoprotein complex subunit 3 (NOP10) CSB-YP738918CZI
CSB-EP738918CZI
CSB-BP738918CZI
CSB-MP738918CZI
CSB-EP738918CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Pre-mRNA-splicing factor CWC2 (CWC2) CSB-YP738919CZI
CSB-EP738919CZI
CSB-BP738919CZI
CSB-MP738919CZI
CSB-EP738919CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Probable nucleolar complex protein 14 (NOP14), partial CSB-YP738920CZI
CSB-EP738920CZI
CSB-BP738920CZI
CSB-MP738920CZI
CSB-EP738920CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Mediator of RNA polymerase II transcription subunit 16 (SIN4), partial CSB-YP738921CZI
CSB-EP738921CZI
CSB-BP738921CZI
CSB-MP738921CZI
CSB-EP738921CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Adenine deaminase (AAH1) CSB-YP738922CZI
CSB-EP738922CZI
CSB-BP738922CZI
CSB-MP738922CZI
CSB-EP738922CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Oligosaccharide translocation protein RFT1 (RFT1), partial CSB-YP738923CZI
CSB-EP738923CZI
CSB-BP738923CZI
CSB-MP738923CZI
CSB-EP738923CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata JmjC domain-containing histone demethylation protein 1 (JHD1) CSB-YP738924CZI
CSB-EP738924CZI
CSB-BP738924CZI
CSB-MP738924CZI
CSB-EP738924CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata 26S proteasome regulatory subunit RPN1 (RPN1), partial CSB-YP738925CZI
CSB-EP738925CZI
CSB-BP738925CZI
CSB-MP738925CZI
CSB-EP738925CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata tRNA (His) guanylyltransferase (THG1) CSB-YP738926CZI
CSB-EP738926CZI
CSB-BP738926CZI
CSB-MP738926CZI
CSB-EP738926CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata 3-ketodihydrosphingosine reductase TSC10 (TSC10), partial CSB-YP738927CZI1
CSB-EP738927CZI1
CSB-BP738927CZI1
CSB-MP738927CZI1
CSB-EP738927CZI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>